Enzolytics Inc.

OTC:ENZC

0.02 (USD) • At close November 27, 2023
Bedrijfsnaam Enzolytics Inc.
Symbool ENZC
Munteenheid USD
Prijs 0.022
Beurswaarde 53,065,461
Dividendpercentage 0%
52-weken bereik 0.016 - 0.132
Industrie Biotechnology
Sector Healthcare
CEO Mr. Charles S. Cotropia
Website https://enzolytics.com

An error occurred while fetching data.

Over Enzolytics Inc.

Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics.

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)